Toronto-based Myant has announced the launch of a partnership with Mayo Clinic to bring Mayo Clinic’s patented algorithms for heart monitoring and arrhythmia detection to Myant’s SKIIN textile computing platform.
The agreement gives Myant exclusive license to Mayo Clinic’s technology for use in its textile computing or smart clothing projects, including its first generation of SKIIN smart underwear. The collaboration aims to help people at risk of developing Atrial Fibrillation (AFib), and give patients and doctors the ability to proactively monitor heart activity using clothing that detects normal or abnormal heart rhythm.
“The agreement is a huge step forward in our development of a continuous and seamless platform for remote health monitoring and remote diagnosis,” said Tony Chahine, the CEO and founder of Myant. “We are very excited to work with an esteemed organization like Mayo Clinic, and to bring our respective strengths in Textile Computing and heart health monitoring together to help enable better and more productive lives for millions of people.”
“Our collaboration with Myant has the potential to help people access Mayo Clinic healthcare expertise regardless of where they live, and to help those at risk of heart arrhythmias proactively understand and address issues related to their health,” said Paul Friedman, chair of the department of cardiovascular medicine at Mayo Clinic.
Myant’s SKIIN smart underwear will be released in early 2019 pending FDA clearance and Health Canada approval.